A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

As targeted therapies have grown in importance for treating cancers, the ability to detect genetic mutations that tumors carry has as well. While this often involves performing tissue biopsies, there ...

For the first time, fundamental tumor phenotypes determined by a simple blood test Single test now provides molecular tumor typing, subtyping and confirmation of absence of actionable biomarkers to ...

A new liquid biopsy developed by researchers at the University of Chicago is offering a powerful new window into cancer’s earliest stages by flagging subtle shifts in the gut microbiome. Unlike ...

In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a ...

After collecting samples through LabCorp’s patient service centers, the test will be performed within Resolution’s certified laboratory as a lab-developed test. (Getty Images) () Under a partnership ...

CHICAGO — The biggest study to date on new blood tests to detect and analyze cancerous tumors concluded that such "liquid biopsies" are a reliable alternative to conventional biopsies, offering a ...

FDA approval of a Guardant Health blood test that screens for colorectal cancer makes it the first liquid biopsy approved for this type of cancer, clearing the way to make this test more accessible to ...

Fire, smoke, and the roar of a rocket engine blasted the Colorado prairie – the Ablative Mark 1 test was an exciting victory. A student club project at the University of Colorado Boulder, the static ...

A study assessing an experimental cell-free DNA myelination liquid biopsy test was found to be 91% accurate at identifying early-stage epithelial ovarian cancer. A recent analysis investigating the ...